24 May 2013
Keywords: xenical, boosts, weight, loss, cuts, cv, risk
Article | 30 April 2007
Swiss drug major Roche says that data from a new study indicate that its anti-obesity drug Xenical (orlistat) significantly reduces ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 April 2007
© 2013 thepharmaletter.com